Risk factors for invasive fungal disease in critically ill adult patients: A systematic review

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Muskett, Hannah ^a   Shahin, Jason ^a   Eyres, Gavin ^a   Harvey, Sheila ^a   Rowan, Kathy ^a,b   Harrison, David ^a,b  

^a and London School of Hygiene Tropical Medicine   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APACHE; ARTICLE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DIABETES MELLITUS; HUMAN; MEDICAL DECISION MAKING; PARENTERAL NUTRITION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SAMPLE SIZE; SEPSIS; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; ADULT; CRITICAL ILLNESS; INVASIVE CANDIDIASIS; REVIEW; SURGERY; TOTAL PARENTERAL NUTRITION;

ADULT; APACHE; CANDIDIASIS, INVASIVE; CRITICAL ILLNESS; HUMANS; PARENTERAL NUTRITION, TOTAL; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEPSIS; SURGICAL PROCEDURES, OPERATIVE;

EID: 82255179808     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10574     Document Type: Article

References (42)

1. Kauffman CA. Fungal infections. Proc Am Thorac Soc 2006, 3:35-40. 10.1513/pats.200510-110JH, 16493149.
2. Lamagni TL, Evans BG, Shigematsu M, Johnson EM. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9). Epidemiol Infect 2001, 126:397-414. 2869708, 11467797.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39:309-317. 10.1086/421946, 15306996.
4. Health Protection Agency (HPA) Fungal Diseases in the UK: The Current Provision of Support for Diagnosis and Treatment: Assessment and Proposed Network Solution. Report of a working group of the HPA Advisory Committee for Fungal Infection and Superficial Parasites 2006, London: Health Protection Agency, Health Protection Agency (HPA)., http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1196942156347
5. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003, 54:18-24. 10.1016/S0195-6701(03)00085-9, 12767842.
6. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 2003, 37:1172-1177. 10.1086/378745, 14557960.
7. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997, 24:1068-1078. 10.1086/513640, 9195059.
8. Jacobs S, Price Evans DA, Tariq M, Al Omar NF. Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 2003, 31:1938-1946. 10.1097/01.CCM.0000074724.71242.88, 12847386.
9. Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002, 28:1708-1717. 10.1007/s00134-002-1540-y, 12447512.
10. Sandven P, Qvist H, Skovlund E, Giercksky KE, . NORGAS Group and the Norwegian Yeast Study Group Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002, 30:541-547. 10.1097/00003246-200203000-00008, 11990912, NORGAS Group and the Norwegian Yeast Study Group.
11. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001, 233:542-548. 10.1097/00000658-200104000-00010, 1421284, 11303137.
12. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999, 27:1066-1072. 10.1097/00003246-199906000-00019, 10397206.
13. ARDS Network Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network. JAMA 2000, 283:1995-2002. 10.1001/jama.283.15.1995, 10789668, ARDS Network.
14. Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L. Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 1994, 36:20-26. 10.1097/00005373-199401000-00004, 8295245.
15. Yu M, Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993, 21:1635-1642. 10.1097/00003246-199311000-00010, 8222677.
16. Slotman GJ, Burchard KW. Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 1987, 122:147-151. 10.1001/archsurg.1987.01400140029002, 3545141.
17. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2006, 2006(1):CD004920.
18. Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 2006, 57:628-638. 10.1093/jac/dki491, 16459344.
19. Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006, 34:1216-1224. 10.1097/01.CCM.0000208357.05675.C3, 16484923.
20. Ho KM, Lipman J, Dobb GJ, Webb SA. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis. Crit Care 2005, 9:R710-R717. 10.1186/cc3883, 1414000, 16280069.
21. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med 2005, 31:1479-1487. 10.1007/s00134-005-2794-y, 16172847.
22. Shorr AF, Chung K, Jackson WL, Waterman PE, Kollef MH. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005, 33:1928-1936. 10.1097/01.CCM.0000178352.14703.49, 16148461.
23. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52:377-384. 10.1136/jech.52.6.377, 1756728, 9764259.
24. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
25. Mallett S, Royston P, Dutton S, Waters R, Altman DG. Reporting methods in studies developing prognostic models in cancer: a review. BMC Med 2010, 8:20. 10.1186/1741-7015-8-20, 2856521, 20353578.
26. Jordà-Marcos R, Alvarez-Lerma F, Jurado M, Palomar M, Nolla-Salas J, León MA, León C, . EPCAN Study Group Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007, 50:302-310. 10.1111/j.1439-0507.2007.01366.x, 17576324, EPCAN Study Group.
27. León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA, . EPCAN Study Group A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006, 34:730-737. 10.1097/01.CCM.0000202208.37364.7D, 16505659, EPCAN Study Group.
28. Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008, 40:145-153. 10.1080/00365540701534509, 17852926.
29. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP, . National Epidemiology of Mycoses Survey(NEMIS) Study Group Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001, 33:177-186. 10.1086/321811, 11418877, National Epidemiology of Mycoses Survey(NEMIS) Study Group.
30. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, Chawla V, Young JA, Hadley S. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008, 36:1993-1998. 10.1097/CCM.0b013e31816fc4cd, 18552702.
31. Ibàñez-Nolla J, Nolla-Salas M, León MA, García F, Marrugat J, Soria G, Díaz RM, Torres-Rodríguez JM. Early diagnosis of candidiasis in non-neutropenic critically ill patients. J Infect 2004, 48:181-192. 10.1016/S0163-4453(03)00120-8, 14720495.
32. McKinnon PS, Goff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ. Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 2001, 136:1401-1408. 10.1001/archsurg.136.12.1401, 11735868.
33. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758. 10.1097/00000658-199412000-00008, 1234477, 7986142.
34. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: a retrospective case-control study. Arch Surg 1999, 134:657-664. 10.1001/archsurg.134.6.657, 10367877.
35. Paphitou NI, Ostrosky-Zeichner L, Rex JH. Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials. Med Mycol 2005, 43:235-243. 10.1080/13693780410001731619, 16010850.
36. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003, 124:2244-2255. 10.1378/chest.124.6.2244, 14665507.
37. Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007, 26:271-276. 10.1007/s10096-007-0270-z, 17333081.
38. Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, Boillot A. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004, 32:2443-2449. 10.1097/01.CCM.0000147726.62304.7F, 15599149.
39. Steyerberg EW, Eijkemans MJ, Habbema JD. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999, 52:935-942. 10.1016/S0895-4356(99)00103-1, 10513756.
40. León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA, . Cava Study Group Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009, 37:1624-1633. 10.1097/CCM.0b013e31819daa14, 19325481, Cava Study Group.
41. Playford EG, Lipman J, Kabir M, McBryde ES, Nimmo GR, Lau A, Sorrell TC. Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients. Intensive Care Med 2009, 35:2141-2145. 10.1007/s00134-009-1619-9, 19756510.
42. Hermsen ED, Zapapas MK, Maiefski M, Rupp ME, Freifeld AG, Kalil AC. Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 2011, 15:R198. 10.1186/cc10366, 21846332.